James Lindberg to Proto-Oncogene Proteins c-akt
This is a "connection" page, showing publications James Lindberg has written about Proto-Oncogene Proteins c-akt.
Connection Strength
0.106
-
Lindberg JM, Newhook TE, Adair SJ, Walters DM, Kim AJ, Stelow EB, Parsons JT, Bauer TW. Co-treatment with panitumumab and trastuzumab augments response to the MEK inhibitor trametinib in a patient-derived xenograft model of pancreatic cancer. Neoplasia. 2014 Jul; 16(7):562-71.
Score: 0.106